SCHEMBL970312

SCHEMBL970312

O=C(O)N1CCc2cn3nccc3nc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
PDE4B Q07343 2/20 0.33
HPGD P15428 1/20 0.33
PDE4D Q08499 1/20 0.33
HTT P42858 1/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
P2RX7 Q99572 1/20 0.33
GRM5 P41594 1/20 0.33
GAA P10253 1/20 0.33
PDK2 Q15119 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2571824 0.90 GRM5 (0.35) NOTUMALDH1A1TSHRSMN1; SMN2PDE4B
SCHEMBL2406607 0.71 HTR2B (0.36) TSHRNPC1
SCHEMBL29860649 0.71 RIPK1 (0.49) NOTUMALDH1A1TSHRSMN1; SMN2HPGD
SCHEMBL8383914 0.71 RIPK1 (0.49) NOTUMALDH1A1TSHRSMN1; SMN2HPGD
SCHEMBL23701284 0.71 ESR2 (0.36) NOTUMMAPK1SMN1; SMN2HPGDHTT
SCHEMBL27963690 0.70 ABHD6 (0.48) NOTUMALDH1A1MAPK1SMN1; SMN2HPGD
SCHEMBL30613785 0.69 HTR2C (0.51) MAPK1SMN1; SMN2HPGDHTTGRM5
Trifluoroacetic Acid SCHEMBL967950 0.69 HTR2C (0.37)
SCHEMBL22982496 0.68 MAPK1 (0.35) NOTUMALDH1A1TSHRMAPK1SMN1; SMN2
SCHEMBL25432593 0.67 TAS1R3 (0.35) NOTUMALDH1A1TSHRMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
EP-2162451-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES Neurogen Corporation (US) 2010-03-17 EP disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 NOTUM 1991/4885ALDH1A1 812/4885TSHR 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.